Skip to Content

Anti-osteoporotic treatment does reduce the risk of fracture in real-life data

Randomized clinical trials suggest that anti-osteoporotic treatments increase bone mineral density (BMD) and hence reduce the risk of fractures. In this longitudinal cohort study, MD Giovanni Adami, presents the real-life effectiveness of anti-osteoporotic treatment in women at high risk of fracture. Read more: Abstract: OP0239 Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study.

Giovanni Adami

Få tilgang til artikkelen

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top